Why Is Gyre Therapeutics, Inc. (GYRE) Up 19% Today?
Biotech's biggest mover today
Gyre Therapeutics, Inc. is the biggest Biotech gainer on the board today. What follows is what can be sourced about why — and, where nothing can be, that is said plainly rather than filled in.
The move
GYRE trades at $4.76, up +18.7% on the session, with a market capitalisation of $504.7 million.
Volume is 2.5 times the 30-day average, which is the part of a move that tells you whether anyone turned up for it.
Against its 52-week range of $3.97 to $9.14, today's price sits 15% of the way up it.
What can be sourced
The record shows a sector-wide move — Biotech names are up an average of +4.3% today across 255 companies.
None of that is proof of causation. A filing or a target change that lands near a move is context, and the market routinely moves on neither.
What it does do is separate a move with something behind it from one with nothing.
| Metric | Value | Context |
|---|---|---|
| Change today | +18.7% | Biotech average +4.3% |
| Volume | 359,716 | 2.5x the 30-day average |
| Market cap | $504.7 million | Biotechnology |
| Range | $3.97 – $9.14 | 52 weeks |
| Metric | Value | Context |
|---|---|---|
| Change today | +18.7% | Biotech average +4.3% |
| Volume | 359,716 | 2.5x the 30-day average |
| Market cap | $504.7 million | Biotechnology |
| Range | $3.97 – $9.14 | 52 weeks |
The bottom line
A move with something on the record behind it. Whether it holds is a different question. Not investment advice. Summarized from public SEC Form 4 and congressional disclosure data.